Tan, Jenille
Mayo Clinic
Department of Molecular Diagnostics and Cancer Cell Biology, Genentech Inc., South San Francisco, CA 94080, USA
Citations 1
CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma
Burington, Bart, Peng, Yue , Shi, Xiaoyan , Advani, Ranjana H. , Lau, Jeffrey , Stinson, Susanna, Stinson, Jeremy, Januario, Thomas, Vos, Sven de , Ansell, Stephen M. , Forero‐Torres, Andres , Fedorowicz, Grazyna, Yang, Teddy , Elkins, Kristi , Du, Changchun, Mohan, Sankar, Modrušan, Zora , Seshagiri, Somasekar , Yu, Shang‐Fan , Pandita, Ajay , Koeppen, Hartmut , French, Dorothy, Polson, Andrew G. , Offringa, Rienk , Whiting, Nancy, Ebens, Allen , Dornan, David, Tan, Jenille , Yu, Nancy , Advani, Ranjana H , Modrusan, Zora
Science Translational Medicine | March 16, 2011 | Volume: 3 | Issue: 74 | Pages: No page available
A 15-gene expression signature predicts whether a patient with diffuse large B cell lymphoma will respond to dacetuzumab, a therapeutic antibody.